Collaboration is already a growing trend in Life Sciences, where joint ventures, strategic partnerships with academic institutions and biotech incubators or accelerators. The Swiss Life Sciences clusters are particularly well placed to benefit from data sharing and synergies.
The general shift in mindset from competition to cooperation is vital in genomics, where the number of stakeholders is particularly high – think pharma companies, biobanks, genetic interpretation consultants, genetic testing and government projects. Alongside mindsets, players choosing to focus on genomics will be rethinking their operating models as past approaches are no longer fit for the future of personalized medicine.